HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ove Bruland Selected Research

Chronic Brain Damage

12/2016Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.
1/2016Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ove Bruland Research Topics

Disease

13Neoplasms (Cancer)
01/2022 - 08/2002
3Fatigue
12/2016 - 01/2011
3Papillary Thyroid Cancer
12/2009 - 08/2002
2Acoustic Neuroma (Acoustic Neurinoma)
01/2022 - 12/2018
2Chronic Brain Damage
12/2016 - 01/2016
2Carcinogenesis
09/2015 - 03/2012
2Congenital Stromal Corneal Dystrophy
05/2015 - 11/2010
2Carcinoma (Carcinomatosis)
03/2012 - 02/2006
2Squamous Cell Carcinoma of Head and Neck
03/2011 - 11/2008
2Hyperthermia
02/2009 - 03/2008
1Neurofibrosarcoma (MPNST)
01/2022
1Premature Aging
01/2021
1Low Vision (Subnormal Vision)
01/2019
1Myofibromatosis
01/2019
1Acro-Osteolysis (Acroosteolysis)
01/2019
1Lipodystrophy
01/2019
1Progeria (Hutchinson Gilford Syndrome)
01/2019
1Microsatellite Instability
01/2018
1Gaucher Disease (Gaucher's Disease)
01/2017
1Necrosis
01/2016
1Neutropenia
01/2015
1Hypersensitivity (Allergy)
01/2015
1Cognitive Dysfunction
09/2014
1Sjogren's Syndrome (Sjogren Syndrome)
07/2011
1Autoimmune Diseases (Autoimmune Disease)
01/2011
1Lymphoma (Lymphomas)
01/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2011
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2011
1Corneal Opacity
11/2010
1Neurofibromatosis 2 (Neurofibromatosis Type II)
10/2010
1Thyroiditis
12/2009
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2009
1Glioma (Gliomas)
02/2009
1Arachnoid Cysts (Intracranial Arachnoid Cysts)
07/2008
1Meningioma (Meningiomas)
07/2008
1Mouth Neoplasms (Oral Cancer)
11/2007
1Acute Intermittent Porphyria (Porphyria, Acute)
01/2004

Drug/Important Bio-Agent (IBA)

5Biological ProductsIBA
09/2015 - 08/2002
5Proteins (Proteins, Gene)FDA Link
09/2015 - 02/2006
4Messenger RNA (mRNA)IBA
10/2010 - 08/2002
4Complementary DNA (cDNA)IBA
10/2010 - 08/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2008
3Rituximab (Mabthera)FDA Link
01/2016 - 01/2011
3RNA (Ribonucleic Acid)IBA
12/2009 - 07/2008
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2022 - 01/2019
2Oxidoreductases (Dehydrogenase)IBA
12/2016 - 07/2008
2DecorinIBA
05/2015 - 11/2010
2Biomarkers (Surrogate Marker)IBA
12/2009 - 11/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2009 - 03/2008
1Codon (Codons)IBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2019
1Nucleic AcidsIBA
12/2018
1Glucosylceramides (Glucocerebrosides)IBA
01/2017
1Pyruvic Acid (Pyruvate)IBA
12/2016
1B-Cell Activating FactorIBA
01/2016
1Immunoglobulins (Immunoglobulin)IBA
01/2016
1Nonsense Codon (Nonsense Mutation)IBA
09/2014
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
07/2011
1Matrix Metalloproteinases (MMPs)IBA
03/2011
1AutoantibodiesIBA
01/2011
1Transforming Growth Factor beta3 (TGF beta 3)IBA
10/2010
1Thymidylate SynthaseIBA
07/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2006
1OsteopontinIBA
02/2006
1Kallikreins (Kallikrein)IBA
02/2006
1claudin 16IBA
02/2006
1Cadherins (E-Cadherin)IBA
02/2006
1IntegrinsIBA
02/2006
1PotassiumIBA
02/2006
1NucleotidesIBA
02/2006
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2006
1LigandsIBA
02/2006
1Trans-Activators (Trans-Acting Factor)IBA
02/2006
1Fibronectins (Fibronectin)IBA
02/2006
1PeriostinIBA
02/2006
1Claudin-1IBA
02/2006
1Dual-Specificity PhosphatasesIBA
02/2006
1Growth Differentiation Factor 15IBA
02/2006
1Serine Proteases (Serine Protease)IBA
02/2006
1glutaminyl-peptide cyclotransferaseIBA
02/2006
1Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
01/2004

Therapy/Procedure

3Aftercare (After-Treatment)
12/2009 - 08/2008
2Therapeutics
12/2009 - 11/2008
1Ligation
01/2018
1Drug Therapy (Chemotherapy)
01/2011